Bruker Corporation (Nasdaq: BRKR) announces that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems. This acquisition fills a gap in the technology and product portfolio of the Bruker BioSpin Preclinical Imaging (PCI) division, broadening its range of preclinical solutions for disease research. Established in 2009 in Tucson, Spectral Instruments Imaging (SII) is at the forefront of technology for co-registered bioluminescence (BLI), fluorescence (FLI), and X-ray preclinical imaging. SII systems are engineered with advanced optics, patented illumination, -90o C air-cooled high sensitivity cameras, absolute calibration for quantifiable imaging, excellent flexibility and ease of use.
Read the full article: Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems //
Source: https://www.businesswire.com/news/home/20240206814523/en/Bruker-Acquires-Spectral-Instruments-Imaging-the-Performance-Leader-in-Preclinical-In-Vivo-Optical-Imaging-Systems